key: cord-0908432-5erl88or authors: Sadeghi, Morteza; Miroliaei, Mehran title: Inhibitory effects of selected isoquinoline alkaloids against main protease (M(pro)) of SARS-CoV-2, in silico study date: 2022-03-14 journal: In Silico Pharmacol DOI: 10.1007/s40203-022-00122-4 sha: 3c834608d47746ace93b86cadcb77499c54838d4 doc_id: 908432 cord_uid: 5erl88or The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global threat. Despite the production of various vaccines and different treatments, finding natural compounds to control COVID-19 is still a challenging task. Isoquinoline alkaloids are naturally occurring compounds known to have some potential antiviral activity. In this study, ten abundant isoquinoline alkaloids with antiviral activity were selected to analyze the preventive effect on COVID-19. A scrutinized evaluation based on Lipinski’s rule showed that one out of ten compounds was toxic. Based on molecular docking analysis using Autodock software one of the best molecules with maximum negative binding energy was selected for further analysis. The Gromacs simulation analysis revealed that Coptisine has more action against active site M(pro) of COVID-19. Overall, to make a rational design of various preventive analogues that inhibit the COVID-19, associated in vitro and in vivo analyses are needed to confirm this claim. COVID-19 has become a global pandemic to the health care system of almost every country in the world. In late December 2019, a new coronavirus was identified, originally named the 2019 new Corona Virus (nCoV 2019), which developed during the spread of the disease in Wuhan, Hubei Province, China Narkhede et al. 2020; Kumar et al. 2020) . In China, an abrupt prevalence was declared by The Emergency Committee of the World Health Organization (WHO) in late 2020 which was then recognized internationally as a public health emergency (Rodríguez-Morales et al. 2019; Chen et al. 2020) . Afterward, the World Health Organization (WHO) has converted the appellation to coronavirus illness , in February 2020 (Khaerunnisa et al. 2020; Velavan and Meyer 2020; Cao 2020) . According to the WHO, millions of people have been infected with the coronavirus, and this number is increasing. Lately, the complete number of the patient about around the world was reported to be 235,190,113 confirmed cases with more than 4,808,189 deaths (https:// www. world omete rs. info/ coron avirus/). One of the identified drug targets among the coronaviruses is main protease (M pro ), also known as 3CLpro. Amino acid sequences showed that there are many similarities between the main protease of COVID 19 with other SARS-CoV families and the majority of the sequences are conserved. This enzyme plays an important role in the processing of polyproteins translated from viral RNA and it is essential for the efficiency of the virus (Garg and Roy 2020; Alamri et al. 2020; Cao et al. 2020) . Inhibition of this enzyme activity would prevent the proliferation of the virus. Despite the production of various vaccines and different treatments, finding natural compounds to control COVID-19 is still a challenging task. (Uddin et al. 2020; Cortegiani et al. 2020) . Numerous inhibitors such as dipyridamole, candesartan cilexitil, hydroxychloroquine, chloroquine, disulfiram, atazanavir, indinavir, sulfacetamide, cimetidine, maribavir, and candesartan have been introduced to control SARS-CoV-2 M pro (Li et al. 2020) . Isoquinoline alkaloids are important metabolites that contain a variety of biological and medicinal activities (Diamond and Desgagné-Penix 2016) . Isoquinoline alkaloids are found in the plants (families of Papaveraceae, Fumariaceae, Menispermaceae, Annonaceae, and Rutaceae). These compounds are generally composed of the amino acids of PHE and TYR. Isoquinoline ring is an important feature in all of them (Bentley 2001) . Different therapeutic approaches such as antiviral activity, antibacterial, anti-convulsant, anti-tussive, etc., are of special importance (Kukula-Koch and Widelski 2017). Previous studies have tested the effect of selected alkaloids against M pro of COVID-19. The compounds such as Thalimonine, Lycorine, Hemanthamine, Berberine, Hippeastrine, Hirsutine, Fangchinolone, Tetrandrine, Cepharanthine, Skimmianine, and Emetine had the potential to inhibit the M pro (Garg and Roy 2020) . Therefore, in this study, ten isoquinoline alkaloid compounds were selected based on their antiviral activity reported in the literature. Chelidonine is found in Chelidonium majus and possesses diverse biological activities. Its antiviral activity was reported against immunodeficiency virus type 1 (HIV-1) (Da et al. 2015) . Pscychotrine and Cephaeline both can be isolated from the roots of Psychotria nervosa and are being tested for potential activity against HIV-1 reverse transcriptase (Chinsembu 2019) . Fumaricine is derived from Fumaria officinalis and act as an anti-virus (Dey et al. 2020) . Galanthamine is an isoquinoline alkaloid that is extracted from Leucojum aestivum. It is a potent inhibitor of Herpes simplex type 1 viruses (Georgiev et al. 2012) . Glaucine is found in the members of Papaveraceae family and shows various medical importance. Various studies reported its potential antivirus (anti-HIV) (Modarresi et al. 2020) . Boldine was collected from Peumus boldus and has been investigated for the anti-influenza A virus (Zhao et al. 2006) . Hydrastine and Coptisine from Ranunculaceae have been found as potential alkaloids against Hepatitis B virus (HBV) is the causative agent of B-type hepatitis in humans (Orhan et al. 2007 ). This study aimed to investigate the inhibitory nature of isoquinoline alkaloids on Mpro of COVID-19. Therefore, in silico parameters such as toxicity, Lipinski's rule, molecular docking, and molecular dynamics simulation were performed. At first, the isoquinoline alkaloid molecules were fetched from the literature. The 3-dimensional (3D) structure of The study of the toxicity of compounds is an important feature in the selection of a drug molecule. In this study, the toxicity of isoquinoline alkaloids (Hepatotoxicity, Mutagenicity, Carcinogenicity, Cytotoxicity, and Immunotoxicity) and their toxicity class were predicted by the ProTox-II server (tox.charite.de/protox_II/) (Banerjee et al. 2018 ) and Toxtree 2.5.4 tool (Mombelli et al. 2016) , respectively. The potential effective of isoquinoline alkaloids compounds was evaluated using the Lipinski parameter to inhibit the activity of COVID-19 main protease. Items such as Molecular weight (Mw), high lipophilicity, hydrogen bonds donor, hydrogen bonds acceptor, and Molar refractivity were considered for the compounds (Walters 2012; Daina et al. 2017a ). The SwissADME tools (http:// www. swiss adme. ch/ index. php) (Sadeghi and Zarei 2020; Behbahani et al. 2021) and PubChem (http:// pubch em. ncbi. nlm. nih. gov) were used to find Lipinski's rule (Daina et al. 2017b; Sadeghi et al. 2021a ). Autodock (version 4.2) (Sadeghi et al. 2022 (Sadeghi et al. , 2021b Simulation of M pro -ligand was studied using MDs for a time of 10 ns using GROMACS program v4.5.5. (Joshi et al. 2020) . Gromacs 9643a1 was performed as the force field for the simulation of the M pro -ligand complex. The M pro -ligand complex was solvated in SPC/E Water Models (Mark and Nilsson 2001) . After adding the water, the complex was neutralized by adding three ions Na + . The covalent contacts between the atoms were limited by short energy minimization. Then the system was equilibrated in two stages. The first stage contained a fixed number of particles, volume, and temperature (NVT). The second stage included a constant number of particles, pressure, and temperature (NPT). The simulation was performed at 300 K and 1 bar pressure for 10 ns. Covalent bonds and electrostatic interactions were adjusted by Linear Constraint Solver (LINCS) and Mesh Ewald (PME) methods, respectively. Molecular dynamics simulation protocol between receptor-ligand complex was considered by previous reports (Thirumal et al. 2017 ). Finally, the stability of the system was calculated by analysis the root mean square deviations (RMSD), an accessible radius of gyration (Rg), and root mean square fluctuations (RMSF). All selected ligands were tested for toxicity ( Table 2) . One of the important medicinal properties of a compound is its non-toxicity. Therefore, the comparison of toxicity helps to remove toxic ligands. The toxicity of the compounds is divided into six different classes. The I class is highly toxic, the II and III classes are toxic, the IV class is low toxic and the V and VI classes are safe (Zhu et al. 2017 ). The results of analysis showed that among ten selected compounds, one compound had hepatotoxicity and immunotoxicity. So, this compound was removed and the remaining nine compounds were examined for Lipinski parameters. The ten selected compounds were compared according to Lipinski parameters (Table 3) . These parameters remove ligands that may not be drug candidates. In addition to all of Lipinski's parameters of 5, the Veber filter was considered as another parameter for comparing of isoquinoline alkaloids. The eligibility of most parameters does not guarantee a specific substance as a drug. It only gives information about the drug-likeliness of the drug and only helps to eliminate weak ligands in the preclinical stage. The results of Lipinski parameter showed that all selected isoquinoline alkaloids follow this rule, and therefore 9 selected ligands were considered as drug candidates. The interaction was performed between M pro ligand complexes. Molecular docking is one of the important factors in drug design. In this method, the interaction between the receptorligand complexes is predicted, and the docking energy is investigated. The lowest docking energy creates the strongest binding (Sadeghi et al. 2021b) . Natural products like coumarins, flavonoids, terpenoids, and diarylheptanoids are potent inhibitors of the M pro (Paraiso et al. 2020) . In silico and in vitro studies have found that catechin, quercetin, and gallocatechin are potent inhibitors of the M pro (Mahmud et al. 2021) . M pro duplication was inhibited by isoquinoline alkaloids such as cepharanthine, berberine, fangchinoline, berbamine, tetrandrine, coptisine, palmatine, and jatrorrhizine (Chakravarti et al. 2021) . Another in silico study showed that berberine, an isoquinoline alkaloid found in the leaves of Strychnos usambarensis (Gyebi et al. 2021) , cryptoquindoline, and cryptospirolepine, two alkaloids found in Cryptolepis sanguinolenta (Borquaye et al. 2020) , had high binding affinity for M pro . The same study displayed that Hydroxyusambarensine revealed the strongest interactions with M pro of SARS-CoV-2, and Amarogentin exhibited the highest binding affinity and selectivity for M pro of SARS-CoV (Kar et al. 2020 ). All the nine selected ligands were placed in M pro active site. According to previous reports, the active site of the M pro includes the amino acids of GLY143, SER144, CYS145, THR26, HIS163, THR27, and HIS172 (Garg and Roy 2020; Mpiana et al. 2020; Enmozhi et al. 2020) . Docking scores were calculated for all compounds and compared with the standard inhibitor (N3). The binding energy of the N3-M pro complex was − 8.17 kcal/mol. The binding energy of the ligands was ranged from − 4.9 to − 9.15 kcal/mol (Fig. 1) . The results showed that all the compounds had a high potential for binding to M pro . But Coptisine-M pro complex had lower binding energy and stronger bond than N3-M pro complex. In the binding method, N3-M pro complex via three conventional hydrogen bonds (THR26, CYS145, and SER144) as well as eleven van der Waals interactions. However, the Coptisine-M pro complex had better binding energy via four conventional hydrogen bonds (GLY143, SER144, CYS145, and HIS163) and twelve van der Waals interactions ( Fig. 2A , B, C, D). Molecular dynamics is used to study ligand-receptor complexes overtime at the atomic level. various factors such as RMSF, RMSD, and Rg help in understanding the binding template (Sneha and Doss 2016) . Figure 3 depicts the RMSF factor of the N3-M pro complex and Coptisine-M pro complex. RMSF studies the flexibility among the residues in the presence of Coptisine and N3. From the RMSF plot, it was perceived that the Coptisine-M pro complex (fluctuation total = 31.7103) showed a lower fluctuation level than the N3-M pro complex (fluctuation total = 33.8953) indicates the restricted movements during the simulation. Examining RMSD factors provides accurate structural information in understanding the structural stability of any complex. Therefore the RMSD analysis for M pro was performed in the presence of Coptisine ligand as well as N3 inhibitor. According to the results, the equilibrium of both complexes is established up to 5 ns, but after 5 ns the Coptisine-M pro complex shows less deviation. N3-M pro complex achieves equilibrium at 0.19 nm at 10 ns whereas the Coptisine-M pro complex achieves equilibrium at 0.16 nm at 10 ns (Fig. 4) . The lower RMSD factor of the Coptisine-M pro complex indicates higher stability of the Coptisine-M pro complex structure than that of the N3-M pro complex. To observation the total compactness of resistance M pro in the presence of Coptisine and N3, we performed the Rg level of Coptisine-M pro complex and N3-M pro complex (Fig. 5) . From the plot, it is obvious that the Coptisine-M pro complex showed a lesser Rg level than the N3-M pro complex, demonstrated the low conformational changes during the simulation. This lesser the Rg clarify the complex had more compactness and contrariwise. In this study, the aim was to find effective inhibitors among isoquinoline alkaloids against the main protease of COVID 19. Four filtering steps were considered for this purpose. The toxicity of ten ligands was evaluated and nine compounds entered the Lipinski stage. Molecular docking was performed for nine compounds. Among the isoquinoline alkaloids compounds, the Coptisine had the best binding energy compared to the standard inhibitor with a binding energy of − 9.15 kcal/mol. Therefore, molecular dynamics simulations were considered for the Coptisine-M pro complex and N3-M pro complex. RMSD, RMSF, and Rg values were compared for both complexes. It can be concluded that the Coptisine as a natural inhibitor can have a potential effect on the M pro of COVID-19 in silico. The tests in vitro and in vivo are essential to ensure the inhibitory effect of the desired compound. Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro ProTox-II: a webserver for the prediction of toxicity of chemicals In silico design of a multi-epitope peptide construct as a potential vaccine candidate for Influenza A based on neuraminidase protein 2001) β-Phenylethylamines and the isoquinoline alkaloids Alkaloids from Cryptolepis sanguinolenta as potential inhibitors of SARS-CoV-2 viral proteins: an in silico study COVID-19: immunopathology and its implications for therapy A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 A review on potential of natural products in the management of COVID-19 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Chemical diversity and activity profiles of HIV-1 reverse transcriptase inhibitors from plants A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 5-Phytochemical and biological research of Chelidonieae pharmaceutical resources. Medicinal plants chemistry, biology and omics SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules Analysis of alkaloids (indole alkaloids, isoquinoline alkaloids, tropane alkaloids). Recent advances in natural products analysis Metabolic engineering for the production of plant isoquinoline alkaloids Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach In silico analysis of selected alkaloids against main protease (Mpro) of SARS-CoV-2 Galanthamine production by L. eucojum L. aestivum shoot culture in a modified bubble column bioreactor with internal sections Potential inhibitors of coronavirus 3-chymotrypsinlike protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants Rational discovery of dengue type 2 non-competitive inhibitors Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19 Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation Potential inhibitor of COVID-19 main Protease (M pro) from several medicinal plant compounds by molecular docking study Catalytic signature of a heatstable, chimeric human alkaline phosphatase with therapeutic potential PubChem substance and compound databases Antitussive noscapine and antiviral drug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs Plant-based phytochemical screening by targeting main protease of SARS-CoV-2 to design effective potent inhibitors Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K Variations of glaucine, quercetin and kaempferol contents in Nigella arvensis against Al2O3, NiO, and TiO2 nanoparticles In silico prediction of chemically induced mutagenicity: how to use QSAR models and interpret their results. In silico methods for predicting drug toxicity Identification of potential inhibitors of SARS-CoV-2 main protease from Aloe vera compounds: a molecular docking study Recognition of natural products as potential inhibitors of COVID-19 main protease (Mpro): In-silico evidences Antiviral and antimicrobial profiles of selected isoquinoline alkaloids from Fumaria and Corydalis species Potential use of polyphenols in the battle against COVID-19 Going global-travel and the 2019 novel coronavirus Molecular docking studies of some flavone analogues as α-Glucosidase inhibitors In silico investigation of flavanone compounds' inhibitory effects on alpha-amylase enzyme and predicting their inhibitory role in diabetes progression In silico study of garlic (Allium sativum L.)-derived compounds molecular interactions with α-glucosidase Screening cyclooxygenase-2 inhibitors from Allium sativum L. compounds: in silico approach Molecular dynamics: new frontier in personalized medicine A molecular docking and dynamics approach to screen potent inhibitors against fosfomycin resistant enzyme in clinical klebsiella pneumoniae SARS-CoV-2/COVID-19: Viral genomics, epidemiology, vaccines, and therapeutic interventions The COVID-19 epidemic Going further than Lipinski's rule in drug design Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study Antinociceptive and free radical scavenging activities of alkaloids isolated from Lindera angustifolia Chen Feeding toxicity and impact of imidacloprid formulation and mixtures with six representative pesticides at residue concentrations on honey bee physiology (Apis mellifera) Acknowledgements We wish to thank University of Isfahan for their supports.